Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients-A Dose-Finding Study (HORA EST HCC Trial).

Pim HendriksDaphne D D RietbergenArian R van ErkelMinneke J CoenraadMark J ArntzRoel J BenninkAndries E BraatA Stijn L P CrobachOtto M van DeldenTom van der HulleHeinz-Josef KlümpenRutger W van der MeerJ Frank W NijsenCarla S P van RijswijkJoey RoosenBastian N RuijterFrits SmitMette K StamR Bart TakkenbergMaarten E TushuizenFloris H P van VeldenLioe-Fee de Geus-OeiMark C Burgmansnull null

Published in: Cardiovascular and interventional radiology (2022)

Clinicaltrials.gov identifier: NCT03437382.

Keyphrases

early stage
study protocol
radiofrequency ablation
end stage renal disease
randomized controlled trial
clinical trial
chronic kidney disease
newly diagnosed
ejection fraction
open label
phase iii
lymph node